TY - JOUR
T1 - Frailty Changes Predict Mortality in 4 Longitudinal Studies of Aging
AU - Stolz, Erwin
AU - Hoogendijk, Emiel O.
AU - Mayerl, Hannes
AU - Freidl, Wolfgang
N1 - Funding Information: This work received no specific funding. However, this work uses several datasets which have been funded by a number of agencies and grants. The HRS (Health and Retirement Study) is sponsored by the National Institute on Aging (grant number NIA U01AG009740) and is conducted by the University of Michigan. The SHARE data collection has been funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812), FP7 (SHARE-PREP: GA No 211909, SHARE-LEAP: GA No 227822, SHARE M4: GA No 261982) and Horizon 2020 (SHARE-DEV3: GA No 676536, SERISS: GA No 654221) and by DG Employment, Social Affairs & Inclusion. Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C) and from various national funding sources is gratefully acknowledged (www.share-project.org). The English Longitudinal Study of Ageing was developed by a team of researchers based at the University College London, NatCen Social Research, and the Institute for Fiscal Studies. The data were collected by NatCen Social Research. The funding is currently provided by the National Institute of Aging (R01AG017644), and a consortium of UK government departments coordinated by the National Institute for Health Research. The Longitudinal Aging Study Amsterdam is supported by a grant from the Ministry of Health Welfare and Sports, Directorate of Long-Term Care. Publisher Copyright: © 2020 The Author(s) 2020.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - BACKGROUND: Baseline frailty index (FI) values have been shown to predict mortality among older adults, but little is known about the effects of changes in FI on mortality. METHODS: In a coordinated approach, we analyzed data from 4 population-based cohorts: the Health and Retirement Study (HRS), the Survey of Health, Ageing and Retirement in Europe (SHARE), the English Longitudinal Survey of Ageing (ELSA), and the Longitudinal Aging Study Amsterdam (LASA), comprising a total of 24 961 respondents (65+), 95 897 observations, up to 9 repeated FI assessments, and up to 23 years of mortality follow-up. The effect of time-varying FI on mortality was modeled with joint regression models for longitudinal and time-to-event data. RESULTS: Differences (of 0.01) in current FI levels (hazard ratio [HR] = 1.04, 95% credible interval [CI] = 1.03-1.05) and baseline FI levels (HR = 1.03, 95% CI = 1.03-1.05) were consistently associated with mortality across studies. Importantly, individuals with steeper FI growth also had a higher mortality risk: An increase in annual FI growth by 0.01 was associated with an increased mortality risk of HR = 1.56 (95% CI = 1.49-1.63) in HRS, HR = 1.24 (95% CI = 1.13-1.35) in SHARE, HR = 1.40 (95% CI = 1.25-1.52) in ELSA, and HR = 1.71 (95% CI = 1.46-2.01) in LASA. CONCLUSIONS: FI changes predicted mortality independently of baseline FI differences. Repeated assessment of frailty and individual's frailty trajectory could provide a means to anticipate further health deterioration and mortality and could thus support clinical decision making.
AB - BACKGROUND: Baseline frailty index (FI) values have been shown to predict mortality among older adults, but little is known about the effects of changes in FI on mortality. METHODS: In a coordinated approach, we analyzed data from 4 population-based cohorts: the Health and Retirement Study (HRS), the Survey of Health, Ageing and Retirement in Europe (SHARE), the English Longitudinal Survey of Ageing (ELSA), and the Longitudinal Aging Study Amsterdam (LASA), comprising a total of 24 961 respondents (65+), 95 897 observations, up to 9 repeated FI assessments, and up to 23 years of mortality follow-up. The effect of time-varying FI on mortality was modeled with joint regression models for longitudinal and time-to-event data. RESULTS: Differences (of 0.01) in current FI levels (hazard ratio [HR] = 1.04, 95% credible interval [CI] = 1.03-1.05) and baseline FI levels (HR = 1.03, 95% CI = 1.03-1.05) were consistently associated with mortality across studies. Importantly, individuals with steeper FI growth also had a higher mortality risk: An increase in annual FI growth by 0.01 was associated with an increased mortality risk of HR = 1.56 (95% CI = 1.49-1.63) in HRS, HR = 1.24 (95% CI = 1.13-1.35) in SHARE, HR = 1.40 (95% CI = 1.25-1.52) in ELSA, and HR = 1.71 (95% CI = 1.46-2.01) in LASA. CONCLUSIONS: FI changes predicted mortality independently of baseline FI differences. Repeated assessment of frailty and individual's frailty trajectory could provide a means to anticipate further health deterioration and mortality and could thus support clinical decision making.
KW - Epidemiology
KW - Frailty
KW - Mortality
KW - Public health
UR - http://www.scopus.com/inward/record.url?scp=85114204205&partnerID=8YFLogxK
U2 - https://doi.org/10.1093/gerona/glaa266
DO - https://doi.org/10.1093/gerona/glaa266
M3 - Article
C2 - 33103718
SN - 1079-5006
VL - 76
SP - 1619
EP - 1626
JO - The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
JF - The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
IS - 9
ER -